Ondrugdelivery
Ondrugdelivery, a leading name in the pharmaceutical and biotechnology sectors, is headquartered in Great Britain. Founded in 2000, the company has established itself as a pivotal player in drug delivery systems, focusing on innovative solutions that enhance therapeutic efficacy and patient compliance. With a strong presence in Europe and North America, Ondrugdelivery offers a range of services, including drug formulation, delivery device development, and regulatory support. Their unique approach combines cutting-edge technology with extensive industry expertise, setting them apart in a competitive market. Recognised for their commitment to quality and innovation, Ondrugdelivery has achieved significant milestones, including partnerships with major pharmaceutical companies and contributions to groundbreaking research. Their dedication to advancing drug delivery methods continues to solidify their position as a trusted leader in the industry.
DitchCarbon Score
How does Ondrugdelivery's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Media Production industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ondrugdelivery's score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ondrugdelivery's reported carbon emissions
In 2022, Ondrugdelivery reported emissions data indicating a carbon footprint associated with their operations, although specific total emissions figures were not disclosed. The company has not provided information on Scope 1, 2, or 3 emissions, nor have they set any reduction targets or initiatives as part of their climate commitments. The only available data pertains to the emissions generated per dose of their products, specifically 0.0095 kg CO2e for dry powder inhalers (DPIs), but this does not encompass their overall emissions profile. Ondrugdelivery does not appear to inherit emissions data from a parent company, as indicated by the absence of cascaded data. As of now, Ondrugdelivery has not established any significant climate pledges or reduction initiatives, which places them in a context where further commitments may be necessary to align with industry standards for sustainability and carbon reduction.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ondrugdelivery is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
